Ahmed used a Tissue Micro-Array (TMA) to re-evaluate 267 BC patients with the ER-/PR + phenotype, and 92 patients were still defined as ER-/PR + phenotype, which may be because traditional IHC usually can only label one or two antigens in tissues. This evidence concerns the gene PGR and breast cancer.